Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KLRA
KLRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KLRA News
Kailera Therapeutics Shares Drop Over 10% After Trial Data
1d ago
seekingalpha
Kalohexis Files for Potential U.S. IPO
1d ago
seekingalpha
Kailera's HRS-7535 Clinical Trials Show Positive Results
1d ago
Newsfilter
Pfizer Eyes Kailera Acquisition to Expand Weight Loss Portfolio
5d ago
Fool
Kardigan's Shares Rise 1.6% in Successful Nasdaq Debut
Jun 18 2026
Yahoo Finance
Three Innovative Biotechs with Promising Prospects
Jun 16 2026
NASDAQ.COM
Analysis of Three Promising Biotech Companies
Jun 16 2026
Fool
Moderna's Strategic Return and Future Outlook
Jun 15 2026
Yahoo Finance
Parabilis Pharmaceuticals IPO Raises $670 Million, Stock Surges 58%
Jun 12 2026
Fool
Parabilis IPO Sets Record, Promising Biotech Prospects Ahead
Jun 12 2026
NASDAQ.COM
Parabilis Achieves Record Biotech IPO with $670 Million Raise
Jun 12 2026
Yahoo Finance
Clinical Results for Ribupatide Unveiled at ADA
Jun 05 2026
Newsfilter
Kailera Therapeutics Reports Q1 Net Loss of $78.9 Million
May 26 2026
seekingalpha
Kailera Therapeutics Makes Successful IPO Amid Biotech Surge
May 16 2026
Fool
Hengrui Pharma and Kailera Showcase New Drug at ADA
May 13 2026
Newsfilter
Latest Wall Street Ratings Overview
May 12 2026
CNBC
Show More News
